Over the last 7 days, the Biotech industry has dropped 1.2%, driven by Swedish Orphan Biovitrum declining 3.5%. However, the industry is down 5.9% over the past year. Looking forward, earnings are forecast to grow by 37% annually.
Has the Swedish Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 16 Apr 2024 | kr179.8b | kr29.8b | -kr5,279,682,044.88 | 64.7x | -34.1x | 6x |
Thu, 14 Mar 2024 | kr191.0b | kr29.8b | -kr5,636,578,997.81 | 58.3x | -33.9x | 6.4x |
Sat, 10 Feb 2024 | kr176.3b | kr29.6b | -kr5,748,812,027.06 | 60.4x | -30.7x | 6x |
Mon, 08 Jan 2024 | kr183.3b | kr28.7b | -kr1,198,220,759.00 | 59.9x | -153x | 6.4x |
Wed, 06 Dec 2023 | kr174.6b | kr28.7b | -kr1,200,948,861.00 | 58.8x | -145.4x | 6.1x |
Fri, 03 Nov 2023 | kr159.0b | kr28.6b | -kr1,304,911,737.00 | 48.2x | -121.8x | 5.5x |
Sun, 01 Oct 2023 | kr161.8b | kr27.4b | -kr2,016,197,047.00 | 51.3x | -80.2x | 5.9x |
Tue, 29 Aug 2023 | kr154.5b | kr27.6b | -kr1,825,740,116.00 | 52.1x | -84.6x | 5.6x |
Thu, 27 Jul 2023 | kr155.3b | kr27.5b | -kr1,531,665,655.00 | 58.5x | -101.4x | 5.6x |
Sat, 24 Jun 2023 | kr165.6b | kr26.4b | -kr1,312,079,266.00 | 45.9x | -126.2x | 6.3x |
Mon, 22 May 2023 | kr175.1b | kr26.3b | -kr1,411,262,591.00 | 46.7x | -124.1x | 6.6x |
Wed, 19 Apr 2023 | kr176.4b | kr25.4b | -kr2,026,956,582.00 | 41.4x | -87x | 6.9x |
Fri, 17 Mar 2023 | kr168.7b | kr25.4b | -kr2,016,408,138.00 | 38.4x | -83.6x | 6.6x |
Sun, 12 Feb 2023 | kr175.5b | kr25.3b | -kr1,664,914,197.00 | 27.5x | -105.4x | 6.9x |
Tue, 10 Jan 2023 | kr163.9b | kr23.8b | -kr1,842,388,404.00 | 31.5x | -88.9x | 6.9x |
Thu, 08 Dec 2022 | kr156.1b | kr23.8b | -kr1,772,205,741.00 | 31.6x | -88.1x | 6.6x |
Sat, 05 Nov 2022 | kr153.6b | kr23.9b | -kr3,207,931,300.00 | 33x | -47.9x | 6.4x |
Mon, 03 Oct 2022 | kr152.0b | kr22.9b | -kr3,318,606,196.00 | 31.6x | -45.8x | 6.6x |
Wed, 31 Aug 2022 | kr159.2b | kr22.9b | -kr3,299,571,284.00 | 34.6x | -48.2x | 6.9x |
Fri, 29 Jul 2022 | kr169.5b | kr22.7b | -kr3,479,403,770.00 | 35.8x | -48.7x | 7.5x |
Sun, 26 Jun 2022 | kr147.4b | kr21.4b | -kr3,519,963,169.00 | 35.5x | -41.9x | 6.9x |
Tue, 24 May 2022 | kr153.0b | kr21.4b | -kr3,296,370,726.00 | 44.3x | -46.4x | 7.1x |
Thu, 21 Apr 2022 | kr172.5b | kr19.7b | -kr3,200,319,054.00 | 50.6x | -53.9x | 8.8x |
Sat, 19 Mar 2022 | kr167.2b | kr19.6b | -kr3,011,912,350.00 | 51.1x | -55.5x | 8.5x |
Mon, 14 Feb 2022 | kr173.2b | kr19.4b | -kr2,621,958,360.00 | 51.8x | -66.1x | 8.9x |
Wed, 12 Jan 2022 | kr181.7b | kr19.1b | -kr2,003,801,467.00 | 55.2x | -90.7x | 9.5x |
Fri, 10 Dec 2021 | kr191.7b | kr19.0b | -kr1,986,815,119.00 | 53x | -96.5x | 10.1x |
Sun, 07 Nov 2021 | kr203.4b | kr19.0b | -kr1,206,518,191.00 | 55.8x | -168.6x | 10.7x |
Tue, 05 Oct 2021 | kr199.3b | kr18.1b | -kr1,339,262,423.00 | 40.8x | -148.8x | 11x |
Thu, 02 Sep 2021 | kr219.9b | kr18.1b | -kr1,175,418,285.95 | 60.1x | -187.1x | 12.1x |
Sat, 31 Jul 2021 | kr194.3b | kr18.1b | -kr1,175,418,285.95 | 62x | -165.3x | 10.7x |
Tue, 04 May 2021 | kr157.4b | kr17.8b | -kr1,319,393,930.10 | 43.4x | -119.3x | 8.9x |
-119.3x
How does Swedish Biotech compare with similar industries?
SE Market | -1.31% | |
Healthcare | -1.86% | |
Biotech | -1.33% | |
Biotech | -1.33% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
VITR Vitrolife | kr191.00 | 2.6% +kr649.9m | -11.8% | PS7.4x | |
CRNO B Cereno Scientific | kr4.35 | 8.7% +kr286.7m | 131.1% | PS24.8x | |
BIOG B BioGaia | kr118.70 | 2.4% +kr282.8m | 29.2% | PE32.8x | |
BONEX Bonesupport Holding | kr241.20 | 1.2% +kr184.0m | 165.5% | PE64.7x | |
PROB Probi | kr223.00 | 4.7% +kr113.9m | 19.3% | PE151.1x |